搜索临床试验以:Epstein-Barr 病毒特异性免疫疗法
总计65个结果
-
Northwestern UniversityNational Cancer Institute (NCI)完全的
-
University of Alabama at Birmingham撤销
-
Baylor College of MedicineThe Methodist Hospital Research Institute招聘中
-
Baylor College of MedicineThe Methodist Hospital Research Institute撤销
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy, Baylor College...尚未招聘霍奇金淋巴瘤 | 非霍奇金淋巴瘤 | 外周T细胞淋巴瘤 | 间变性大细胞淋巴瘤,ALK 阳性 | 间变性大细胞淋巴瘤,ALK 阴性 | CD30 阳性弥漫性大 B 细胞淋巴瘤 | 间变性大细胞淋巴瘤、T 细胞和无效细胞类型美国
-
Atara Biotherapeutics终止
-
Atara BiotherapeuticsMerck Sharp & Dohme LLC终止鼻咽癌 | 鼻咽肿瘤 | 爱泼斯坦-巴尔病毒感染 | 爱泼斯坦-巴尔病毒血症 | Epstein-Barr 病毒相关性鼻咽癌 (EBV+ NPC)美国
-
Atara BiotherapeuticsNational Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center完全的
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Massachusetts General Hospital; Brigham and Women's Hospital完全的
-
National Cancer Centre, Singapore未知
-
Milton S. Hershey Medical CenterNational Cancer Institute (NCI)未知
-
Chinese University of Hong Kong完全的
-
Hanoi Medical UniversityKarolinska Institutet; Swedish International Development Cooperation Agency (SIDA)完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)招聘中造血和淋巴细胞肿瘤 | 恶性实体肿瘤 | BK 病毒感染 | 有症状的 COVID-19 感染实验室确认 | 腺病毒感染 | 巨细胞病毒感染 | JC 病毒感染美国
-
Peking University People's Hospital尚未招聘干细胞移植 | 巨细胞病毒感染 | EB病毒感染
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy, Baylor College...完全的爱泼斯坦-巴尔病毒感染 | 干细胞移植 | 巨细胞病毒感染 | 腺病毒感染美国
-
Ankara University未知
-
Allergopharma GmbH & Co. KG完全的
-
Children's Mercy Hospital Kansas CityCenter for Cell and Gene Therapy, Baylor College of Medicine完全的
-
Allergopharma GmbH & Co. KG完全的
-
Abbott Nutrition完全的
-
Casa Espirita Terra de IsmaelFundação de Amparo à Pesquisa do Estado de São Paulo完全的
-
Johann Wolfgang Goethe University HospitalAllergopharma GmbH & Co. KG完全的
-
Allergopharma GmbH & Co. KGInflamax Research Incorporated终止
-
Allergopharma GmbH & Co. KG完全的
-
Tianjin Medical University Cancer Institute and...未知